Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

1
Player Avatar tenmiles (99.58) Submitted: 11/13/2007 11:12:34 AM : Underperform Start Price: $2.48 QCOR Score: -3,624.86

technical short after pop on MS drug sales growth - current price unsustainable

Member Avatar EnigmaDude (92.72) Submitted: 7/28/2011 1:15:34 PM
Recs: 0

You were right about that! The price has climbed steadily since you wrote this to now over $32! Will you ever change your mind and close this pick?

Featured Broker Partners


Advertisement